nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethotoin—CYP2C19—prostate cancer	0.376	1	CbGaD
Ethotoin—CYP2C19—Nilutamide—prostate cancer	0.0774	0.288	CbGbCtD
Ethotoin—CYP2C19—Bicalutamide—prostate cancer	0.0774	0.288	CbGbCtD
Ethotoin—CYP2C19—Flutamide—prostate cancer	0.0641	0.239	CbGbCtD
Ethotoin—CYP2C19—Estradiol—prostate cancer	0.0266	0.0992	CbGbCtD
Ethotoin—CYP2C19—Prednisone—prostate cancer	0.0229	0.0853	CbGbCtD
Ethotoin—SCN7A—prostate gland—prostate cancer	0.00436	0.128	CbGeAlD
Ethotoin—CYP2C19—urine—prostate cancer	0.00424	0.125	CbGeAlD
Ethotoin—SCN9A—prostate gland—prostate cancer	0.00341	0.101	CbGeAlD
Ethotoin—SCN4A—prostate gland—prostate cancer	0.00305	0.0898	CbGeAlD
Ethotoin—SCN3A—prostate gland—prostate cancer	0.00237	0.0698	CbGeAlD
Ethotoin—SCN4A—renal system—prostate cancer	0.00208	0.0612	CbGeAlD
Ethotoin—SCN7A—testis—prostate cancer	0.00192	0.0566	CbGeAlD
Ethotoin—SCN8A—testis—prostate cancer	0.00171	0.0504	CbGeAlD
Ethotoin—Systemic lupus erythematosus—Docetaxel—prostate cancer	0.00164	0.011	CcSEcCtD
Ethotoin—Sensory loss—Estradiol—prostate cancer	0.00162	0.0109	CcSEcCtD
Ethotoin—SCN3A—renal system—prostate cancer	0.00161	0.0476	CbGeAlD
Ethotoin—Hypoaesthesia—Degarelix—prostate cancer	0.00158	0.0106	CcSEcCtD
Ethotoin—Erythema multiforme—Estradiol valerate/Dienogest—prostate cancer	0.00158	0.0106	CcSEcCtD
Ethotoin—SCN9A—testis—prostate cancer	0.0015	0.0443	CbGeAlD
Ethotoin—Hypoaesthesia—Cabazitaxel—prostate cancer	0.00149	0.01	CcSEcCtD
Ethotoin—Chest pain—Estramustine—prostate cancer	0.00148	0.00999	CcSEcCtD
Ethotoin—Chest pain—Abiraterone—prostate cancer	0.00144	0.0097	CcSEcCtD
Ethotoin—SCN7A—lymph node—prostate cancer	0.00139	0.041	CbGeAlD
Ethotoin—SCN4A—testis—prostate cancer	0.00134	0.0395	CbGeAlD
Ethotoin—Numbness—Etoposide—prostate cancer	0.00132	0.00887	CcSEcCtD
Ethotoin—Chest pain—Nilutamide—prostate cancer	0.00132	0.00886	CcSEcCtD
Ethotoin—Insomnia—Estramustine—prostate cancer	0.00129	0.00866	CcSEcCtD
Ethotoin—Sensory loss—Etoposide—prostate cancer	0.00126	0.00848	CcSEcCtD
Ethotoin—Insomnia—Abiraterone—prostate cancer	0.00125	0.00841	CcSEcCtD
Ethotoin—SCN3A—bone marrow—prostate cancer	0.00122	0.036	CbGeAlD
Ethotoin—Lymphadenopathy—Estradiol—prostate cancer	0.0012	0.00807	CcSEcCtD
Ethotoin—Fatigue—Abiraterone—prostate cancer	0.00119	0.00802	CcSEcCtD
Ethotoin—Insomnia—Nilutamide—prostate cancer	0.00114	0.00769	CcSEcCtD
Ethotoin—Insomnia—Flutamide—prostate cancer	0.00114	0.00765	CcSEcCtD
Ethotoin—Chest pain—Cabazitaxel—prostate cancer	0.00111	0.00746	CcSEcCtD
Ethotoin—Body temperature increased—Abiraterone—prostate cancer	0.00109	0.00735	CcSEcCtD
Ethotoin—SCN9A—lymph node—prostate cancer	0.00109	0.0321	CbGeAlD
Ethotoin—Fatigue—Flutamide—prostate cancer	0.00108	0.00729	CcSEcCtD
Ethotoin—Hypoaesthesia—Ethinyl Estradiol—prostate cancer	0.00108	0.00726	CcSEcCtD
Ethotoin—SCN3A—testis—prostate cancer	0.00104	0.0308	CbGeAlD
Ethotoin—Erythema multiforme—Ethinyl Estradiol—prostate cancer	0.00102	0.0069	CcSEcCtD
Ethotoin—Fatigue—Estradiol valerate/Dienogest—prostate cancer	0.00102	0.00688	CcSEcCtD
Ethotoin—Insomnia—Degarelix—prostate cancer	0.00102	0.00687	CcSEcCtD
Ethotoin—Body temperature increased—Nilutamide—prostate cancer	0.000997	0.00672	CcSEcCtD
Ethotoin—Asthenia—Abiraterone—prostate cancer	0.00099	0.00667	CcSEcCtD
Ethotoin—Diarrhoea—Estramustine—prostate cancer	0.000972	0.00655	CcSEcCtD
Ethotoin—Fatigue—Degarelix—prostate cancer	0.000971	0.00654	CcSEcCtD
Ethotoin—Chest pain—Bicalutamide—prostate cancer	0.000949	0.0064	CcSEcCtD
Ethotoin—Diarrhoea—Abiraterone—prostate cancer	0.000944	0.00636	CcSEcCtD
Ethotoin—Fatigue—Cabazitaxel—prostate cancer	0.000915	0.00617	CcSEcCtD
Ethotoin—Asthenia—Nilutamide—prostate cancer	0.000905	0.0061	CcSEcCtD
Ethotoin—Vomiting—Estramustine—prostate cancer	0.000903	0.00609	CcSEcCtD
Ethotoin—Asthenia—Flutamide—prostate cancer	0.000901	0.00607	CcSEcCtD
Ethotoin—Dizziness—Estrone—prostate cancer	0.000898	0.00605	CcSEcCtD
Ethotoin—Rash—Estramustine—prostate cancer	0.000896	0.00604	CcSEcCtD
Ethotoin—Dermatitis—Estramustine—prostate cancer	0.000895	0.00603	CcSEcCtD
Ethotoin—Body temperature increased—Degarelix—prostate cancer	0.00089	0.006	CcSEcCtD
Ethotoin—Headache—Estramustine—prostate cancer	0.00089	0.006	CcSEcCtD
Ethotoin—Hypoaesthesia—Conjugated Estrogens—prostate cancer	0.000878	0.00592	CcSEcCtD
Ethotoin—Vomiting—Abiraterone—prostate cancer	0.000877	0.00591	CcSEcCtD
Ethotoin—Rash—Abiraterone—prostate cancer	0.00087	0.00586	CcSEcCtD
Ethotoin—Dermatitis—Abiraterone—prostate cancer	0.000869	0.00586	CcSEcCtD
Ethotoin—Vomiting—Estrone—prostate cancer	0.000863	0.00582	CcSEcCtD
Ethotoin—Diarrhoea—Nilutamide—prostate cancer	0.000863	0.00581	CcSEcCtD
Ethotoin—Diarrhoea—Flutamide—prostate cancer	0.000859	0.00579	CcSEcCtD
Ethotoin—Rash—Estrone—prostate cancer	0.000856	0.00577	CcSEcCtD
Ethotoin—Nystagmus—Epirubicin—prostate cancer	0.000856	0.00577	CcSEcCtD
Ethotoin—Dermatitis—Estrone—prostate cancer	0.000855	0.00576	CcSEcCtD
Ethotoin—Headache—Estrone—prostate cancer	0.00085	0.00573	CcSEcCtD
Ethotoin—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.00085	0.00573	CcSEcCtD
Ethotoin—Nausea—Estramustine—prostate cancer	0.000844	0.00569	CcSEcCtD
Ethotoin—Body temperature increased—Cabazitaxel—prostate cancer	0.000839	0.00565	CcSEcCtD
Ethotoin—Erythema multiforme—Conjugated Estrogens—prostate cancer	0.000835	0.00563	CcSEcCtD
Ethotoin—Dizziness—Nilutamide—prostate cancer	0.000834	0.00562	CcSEcCtD
Ethotoin—Dizziness—Flutamide—prostate cancer	0.00083	0.00559	CcSEcCtD
Ethotoin—SCN10A—lymph node—prostate cancer	0.00083	0.0245	CbGeAlD
Ethotoin—Insomnia—Bicalutamide—prostate cancer	0.000823	0.00555	CcSEcCtD
Ethotoin—Asthenia—Degarelix—prostate cancer	0.000808	0.00545	CcSEcCtD
Ethotoin—Nausea—Estrone—prostate cancer	0.000806	0.00543	CcSEcCtD
Ethotoin—Vomiting—Nilutamide—prostate cancer	0.000802	0.0054	CcSEcCtD
Ethotoin—Vomiting—Flutamide—prostate cancer	0.000798	0.00538	CcSEcCtD
Ethotoin—Rash—Nilutamide—prostate cancer	0.000795	0.00536	CcSEcCtD
Ethotoin—Dermatitis—Nilutamide—prostate cancer	0.000794	0.00535	CcSEcCtD
Ethotoin—Nystagmus—Doxorubicin—prostate cancer	0.000792	0.00534	CcSEcCtD
Ethotoin—Rash—Flutamide—prostate cancer	0.000791	0.00533	CcSEcCtD
Ethotoin—Dermatitis—Flutamide—prostate cancer	0.000791	0.00533	CcSEcCtD
Ethotoin—Headache—Nilutamide—prostate cancer	0.00079	0.00532	CcSEcCtD
Ethotoin—Headache—Flutamide—prostate cancer	0.000786	0.0053	CcSEcCtD
Ethotoin—Fatigue—Bicalutamide—prostate cancer	0.000785	0.00529	CcSEcCtD
Ethotoin—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000783	0.00528	CcSEcCtD
Ethotoin—Diarrhoea—Degarelix—prostate cancer	0.000771	0.00519	CcSEcCtD
Ethotoin—Asthenia—Cabazitaxel—prostate cancer	0.000761	0.00513	CcSEcCtD
Ethotoin—SCN3A—lymph node—prostate cancer	0.000756	0.0223	CbGeAlD
Ethotoin—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000753	0.00508	CcSEcCtD
Ethotoin—Nausea—Nilutamide—prostate cancer	0.000749	0.00505	CcSEcCtD
Ethotoin—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000747	0.00503	CcSEcCtD
Ethotoin—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000746	0.00503	CcSEcCtD
Ethotoin—Nausea—Flutamide—prostate cancer	0.000746	0.00502	CcSEcCtD
Ethotoin—Dizziness—Degarelix—prostate cancer	0.000745	0.00502	CcSEcCtD
Ethotoin—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000742	0.005	CcSEcCtD
Ethotoin—Diarrhoea—Cabazitaxel—prostate cancer	0.000726	0.00489	CcSEcCtD
Ethotoin—Body temperature increased—Bicalutamide—prostate cancer	0.000719	0.00485	CcSEcCtD
Ethotoin—Vomiting—Degarelix—prostate cancer	0.000716	0.00483	CcSEcCtD
Ethotoin—Rash—Degarelix—prostate cancer	0.00071	0.00479	CcSEcCtD
Ethotoin—Dermatitis—Degarelix—prostate cancer	0.000709	0.00478	CcSEcCtD
Ethotoin—Headache—Degarelix—prostate cancer	0.000706	0.00476	CcSEcCtD
Ethotoin—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000704	0.00474	CcSEcCtD
Ethotoin—Hypoaesthesia—Estradiol—prostate cancer	0.000703	0.00474	CcSEcCtD
Ethotoin—Dizziness—Cabazitaxel—prostate cancer	0.000702	0.00473	CcSEcCtD
Ethotoin—Vomiting—Cabazitaxel—prostate cancer	0.000675	0.00455	CcSEcCtD
Ethotoin—Nausea—Degarelix—prostate cancer	0.000669	0.00451	CcSEcCtD
Ethotoin—Erythema multiforme—Estradiol—prostate cancer	0.000668	0.0045	CcSEcCtD
Ethotoin—Headache—Cabazitaxel—prostate cancer	0.000665	0.00448	CcSEcCtD
Ethotoin—Fatigue—Ethinyl Estradiol—prostate cancer	0.000663	0.00447	CcSEcCtD
Ethotoin—Chest pain—Goserelin—prostate cancer	0.00066	0.00445	CcSEcCtD
Ethotoin—Chest pain—Conjugated Estrogens—prostate cancer	0.000654	0.00441	CcSEcCtD
Ethotoin—Asthenia—Bicalutamide—prostate cancer	0.000653	0.0044	CcSEcCtD
Ethotoin—Diplopia—Capecitabine—prostate cancer	0.000637	0.00429	CcSEcCtD
Ethotoin—Nausea—Cabazitaxel—prostate cancer	0.00063	0.00425	CcSEcCtD
Ethotoin—Diarrhoea—Bicalutamide—prostate cancer	0.000623	0.0042	CcSEcCtD
Ethotoin—Ataxia—Docetaxel—prostate cancer	0.000618	0.00417	CcSEcCtD
Ethotoin—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000608	0.0041	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Etoposide—prostate cancer	0.000605	0.00408	CcSEcCtD
Ethotoin—Dizziness—Bicalutamide—prostate cancer	0.000602	0.00406	CcSEcCtD
Ethotoin—Ataxia—Capecitabine—prostate cancer	0.000599	0.00404	CcSEcCtD
Ethotoin—Vomiting—Bicalutamide—prostate cancer	0.000579	0.0039	CcSEcCtD
Ethotoin—Tranylcypromine—CYP2A6—prostate cancer	0.000578	0.0928	CrCbGaD
Ethotoin—Rash—Bicalutamide—prostate cancer	0.000574	0.00387	CcSEcCtD
Ethotoin—Dermatitis—Bicalutamide—prostate cancer	0.000573	0.00386	CcSEcCtD
Ethotoin—Insomnia—Goserelin—prostate cancer	0.000573	0.00386	CcSEcCtD
Ethotoin—Headache—Bicalutamide—prostate cancer	0.00057	0.00384	CcSEcCtD
Ethotoin—Insomnia—Conjugated Estrogens—prostate cancer	0.000567	0.00382	CcSEcCtD
Ethotoin—Methsuximide—CYP2C19—prostate cancer	0.000563	0.0903	CrCbGaD
Ethotoin—Asthenia—Ethinyl Estradiol—prostate cancer	0.000552	0.00372	CcSEcCtD
Ethotoin—Fatigue—Goserelin—prostate cancer	0.000546	0.00368	CcSEcCtD
Ethotoin—Hypoaesthesia—Etoposide—prostate cancer	0.000545	0.00367	CcSEcCtD
Ethotoin—Phensuximide—CYP2C19—prostate cancer	0.000545	0.0874	CrCbGaD
Ethotoin—Fatigue—Conjugated Estrogens—prostate cancer	0.000541	0.00364	CcSEcCtD
Ethotoin—Nausea—Bicalutamide—prostate cancer	0.000541	0.00364	CcSEcCtD
Ethotoin—Phenobarbital—CYP2C18—prostate cancer	0.000527	0.0846	CrCbGaD
Ethotoin—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000526	0.00355	CcSEcCtD
Ethotoin—Chest pain—Estradiol—prostate cancer	0.000524	0.00353	CcSEcCtD
Ethotoin—Lymphadenopathy—Epirubicin—prostate cancer	0.00052	0.0035	CcSEcCtD
Ethotoin—Erythema multiforme—Etoposide—prostate cancer	0.000518	0.00349	CcSEcCtD
Ethotoin—Dizziness—Ethinyl Estradiol—prostate cancer	0.000509	0.00343	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000503	0.00339	CcSEcCtD
Ethotoin—Body temperature increased—Goserelin—prostate cancer	0.000501	0.00337	CcSEcCtD
Ethotoin—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000496	0.00334	CcSEcCtD
Ethotoin—Vomiting—Ethinyl Estradiol—prostate cancer	0.000489	0.0033	CcSEcCtD
Ethotoin—Chest pain—Mitoxantrone—prostate cancer	0.000488	0.00329	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000487	0.00328	CcSEcCtD
Ethotoin—Rash—Ethinyl Estradiol—prostate cancer	0.000485	0.00327	CcSEcCtD
Ethotoin—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000485	0.00327	CcSEcCtD
Ethotoin—Headache—Ethinyl Estradiol—prostate cancer	0.000482	0.00325	CcSEcCtD
Ethotoin—Lymphadenopathy—Doxorubicin—prostate cancer	0.000481	0.00324	CcSEcCtD
Ethotoin—Nausea—Ethinyl Estradiol—prostate cancer	0.000457	0.00308	CcSEcCtD
Ethotoin—Asthenia—Goserelin—prostate cancer	0.000454	0.00306	CcSEcCtD
Ethotoin—Insomnia—Estradiol—prostate cancer	0.000454	0.00306	CcSEcCtD
Ethotoin—Hypoaesthesia—Docetaxel—prostate cancer	0.000453	0.00305	CcSEcCtD
Ethotoin—Asthenia—Conjugated Estrogens—prostate cancer	0.00045	0.00303	CcSEcCtD
Ethotoin—Diplopia—Epirubicin—prostate cancer	0.000444	0.00299	CcSEcCtD
Ethotoin—Hypoaesthesia—Capecitabine—prostate cancer	0.000438	0.00295	CcSEcCtD
Ethotoin—Phenobarbital—CYP1B1—prostate cancer	0.000436	0.0699	CrCbGaD
Ethotoin—Diarrhoea—Goserelin—prostate cancer	0.000433	0.00292	CcSEcCtD
Ethotoin—Fatigue—Estradiol—prostate cancer	0.000433	0.00292	CcSEcCtD
Ethotoin—Erythema multiforme—Docetaxel—prostate cancer	0.00043	0.0029	CcSEcCtD
Ethotoin—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000429	0.00289	CcSEcCtD
Ethotoin—Dizziness—Goserelin—prostate cancer	0.000419	0.00282	CcSEcCtD
Ethotoin—Ataxia—Epirubicin—prostate cancer	0.000417	0.00281	CcSEcCtD
Ethotoin—Erythema multiforme—Capecitabine—prostate cancer	0.000417	0.00281	CcSEcCtD
Ethotoin—Dizziness—Conjugated Estrogens—prostate cancer	0.000415	0.0028	CcSEcCtD
Ethotoin—Tranylcypromine—CYP2E1—prostate cancer	0.000411	0.0659	CrCbGaD
Ethotoin—Diplopia—Doxorubicin—prostate cancer	0.000411	0.00277	CcSEcCtD
Ethotoin—Tranylcypromine—CYP2C19—prostate cancer	0.000407	0.0653	CrCbGaD
Ethotoin—Chest pain—Etoposide—prostate cancer	0.000406	0.00274	CcSEcCtD
Ethotoin—Fatigue—Mitoxantrone—prostate cancer	0.000403	0.00272	CcSEcCtD
Ethotoin—Vomiting—Goserelin—prostate cancer	0.000403	0.00271	CcSEcCtD
Ethotoin—Rash—Goserelin—prostate cancer	0.000399	0.00269	CcSEcCtD
Ethotoin—Dermatitis—Goserelin—prostate cancer	0.000399	0.00269	CcSEcCtD
Ethotoin—Vomiting—Conjugated Estrogens—prostate cancer	0.000399	0.00269	CcSEcCtD
Ethotoin—Body temperature increased—Estradiol—prostate cancer	0.000397	0.00267	CcSEcCtD
Ethotoin—Headache—Goserelin—prostate cancer	0.000397	0.00267	CcSEcCtD
Ethotoin—Rash—Conjugated Estrogens—prostate cancer	0.000395	0.00267	CcSEcCtD
Ethotoin—Dermatitis—Conjugated Estrogens—prostate cancer	0.000395	0.00266	CcSEcCtD
Ethotoin—Headache—Conjugated Estrogens—prostate cancer	0.000393	0.00265	CcSEcCtD
Ethotoin—Ataxia—Doxorubicin—prostate cancer	0.000386	0.0026	CcSEcCtD
Ethotoin—Nausea—Goserelin—prostate cancer	0.000376	0.00253	CcSEcCtD
Ethotoin—Primidone—CYP2C19—prostate cancer	0.000374	0.0601	CrCbGaD
Ethotoin—Nausea—Conjugated Estrogens—prostate cancer	0.000373	0.00251	CcSEcCtD
Ethotoin—Body temperature increased—Mitoxantrone—prostate cancer	0.00037	0.00249	CcSEcCtD
Ethotoin—Asthenia—Estradiol—prostate cancer	0.00036	0.00243	CcSEcCtD
Ethotoin—Methylphenobarbital—CYP2C19—prostate cancer	0.000351	0.0563	CrCbGaD
Ethotoin—Phenobarbital—CYP3A5—prostate cancer	0.000347	0.0557	CrCbGaD
Ethotoin—Diarrhoea—Estradiol—prostate cancer	0.000343	0.00231	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000339	0.00228	CcSEcCtD
Ethotoin—Chest pain—Docetaxel—prostate cancer	0.000337	0.00227	CcSEcCtD
Ethotoin—Phenobarbital—CYP2A6—prostate cancer	0.000336	0.0539	CrCbGaD
Ethotoin—Asthenia—Mitoxantrone—prostate cancer	0.000336	0.00226	CcSEcCtD
Ethotoin—Fatigue—Etoposide—prostate cancer	0.000335	0.00226	CcSEcCtD
Ethotoin—Dizziness—Estradiol—prostate cancer	0.000332	0.00224	CcSEcCtD
Ethotoin—Chest pain—Capecitabine—prostate cancer	0.000327	0.0022	CcSEcCtD
Ethotoin—Diarrhoea—Mitoxantrone—prostate cancer	0.00032	0.00216	CcSEcCtD
Ethotoin—Vomiting—Estradiol—prostate cancer	0.000319	0.00215	CcSEcCtD
Ethotoin—Rash—Estradiol—prostate cancer	0.000316	0.00213	CcSEcCtD
Ethotoin—Dermatitis—Estradiol—prostate cancer	0.000316	0.00213	CcSEcCtD
Ethotoin—Headache—Estradiol—prostate cancer	0.000314	0.00212	CcSEcCtD
Ethotoin—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000314	0.00211	CcSEcCtD
Ethotoin—Body temperature increased—Etoposide—prostate cancer	0.000308	0.00207	CcSEcCtD
Ethotoin—Hypoaesthesia—Epirubicin—prostate cancer	0.000305	0.00206	CcSEcCtD
Ethotoin—Nausea—Estradiol—prostate cancer	0.000298	0.00201	CcSEcCtD
Ethotoin—Vomiting—Mitoxantrone—prostate cancer	0.000297	0.002	CcSEcCtD
Ethotoin—Rash—Mitoxantrone—prostate cancer	0.000295	0.00199	CcSEcCtD
Ethotoin—Dermatitis—Mitoxantrone—prostate cancer	0.000295	0.00199	CcSEcCtD
Ethotoin—Headache—Mitoxantrone—prostate cancer	0.000293	0.00197	CcSEcCtD
Ethotoin—Insomnia—Docetaxel—prostate cancer	0.000292	0.00197	CcSEcCtD
Ethotoin—Erythema multiforme—Epirubicin—prostate cancer	0.00029	0.00196	CcSEcCtD
Ethotoin—Insomnia—Capecitabine—prostate cancer	0.000283	0.00191	CcSEcCtD
Ethotoin—Hypoaesthesia—Doxorubicin—prostate cancer	0.000283	0.0019	CcSEcCtD
Ethotoin—Asthenia—Etoposide—prostate cancer	0.000279	0.00188	CcSEcCtD
Ethotoin—Fatigue—Docetaxel—prostate cancer	0.000279	0.00188	CcSEcCtD
Ethotoin—Nausea—Mitoxantrone—prostate cancer	0.000278	0.00187	CcSEcCtD
Ethotoin—Fatigue—Capecitabine—prostate cancer	0.00027	0.00182	CcSEcCtD
Ethotoin—Erythema multiforme—Doxorubicin—prostate cancer	0.000269	0.00181	CcSEcCtD
Ethotoin—Diarrhoea—Etoposide—prostate cancer	0.000266	0.00179	CcSEcCtD
Ethotoin—Tranylcypromine—CYP3A4—prostate cancer	0.000259	0.0415	CrCbGaD
Ethotoin—Dizziness—Etoposide—prostate cancer	0.000257	0.00173	CcSEcCtD
Ethotoin—Body temperature increased—Docetaxel—prostate cancer	0.000256	0.00172	CcSEcCtD
Ethotoin—Insomnia—Prednisone—prostate cancer	0.000252	0.0017	CcSEcCtD
Ethotoin—Body temperature increased—Capecitabine—prostate cancer	0.000247	0.00167	CcSEcCtD
Ethotoin—Vomiting—Etoposide—prostate cancer	0.000247	0.00167	CcSEcCtD
Ethotoin—Rash—Etoposide—prostate cancer	0.000245	0.00165	CcSEcCtD
Ethotoin—Dermatitis—Etoposide—prostate cancer	0.000245	0.00165	CcSEcCtD
Ethotoin—Headache—Etoposide—prostate cancer	0.000244	0.00164	CcSEcCtD
Ethotoin—Fatigue—Prednisone—prostate cancer	0.00024	0.00162	CcSEcCtD
Ethotoin—Phenobarbital—CYP2E1—prostate cancer	0.000239	0.0383	CrCbGaD
Ethotoin—Primidone—CYP3A4—prostate cancer	0.000238	0.0382	CrCbGaD
Ethotoin—Phenobarbital—CYP2C19—prostate cancer	0.000236	0.0379	CrCbGaD
Ethotoin—Phenobarbital—CYP1A1—prostate cancer	0.000235	0.0378	CrCbGaD
Ethotoin—Asthenia—Docetaxel—prostate cancer	0.000232	0.00156	CcSEcCtD
Ethotoin—Nausea—Etoposide—prostate cancer	0.000231	0.00156	CcSEcCtD
Ethotoin—Chest pain—Epirubicin—prostate cancer	0.000227	0.00153	CcSEcCtD
Ethotoin—Asthenia—Capecitabine—prostate cancer	0.000225	0.00151	CcSEcCtD
Ethotoin—Diarrhoea—Docetaxel—prostate cancer	0.000221	0.00149	CcSEcCtD
Ethotoin—Body temperature increased—Prednisone—prostate cancer	0.00022	0.00149	CcSEcCtD
Ethotoin—Diarrhoea—Capecitabine—prostate cancer	0.000214	0.00144	CcSEcCtD
Ethotoin—Dizziness—Docetaxel—prostate cancer	0.000214	0.00144	CcSEcCtD
Ethotoin—Chest pain—Doxorubicin—prostate cancer	0.00021	0.00142	CcSEcCtD
Ethotoin—Dizziness—Capecitabine—prostate cancer	0.000207	0.0014	CcSEcCtD
Ethotoin—Vomiting—Docetaxel—prostate cancer	0.000206	0.00139	CcSEcCtD
Ethotoin—Rash—Docetaxel—prostate cancer	0.000204	0.00137	CcSEcCtD
Ethotoin—Dermatitis—Docetaxel—prostate cancer	0.000204	0.00137	CcSEcCtD
Ethotoin—Headache—Docetaxel—prostate cancer	0.000203	0.00137	CcSEcCtD
Ethotoin—Asthenia—Prednisone—prostate cancer	0.0002	0.00135	CcSEcCtD
Ethotoin—Vomiting—Capecitabine—prostate cancer	0.000199	0.00134	CcSEcCtD
Ethotoin—Rash—Capecitabine—prostate cancer	0.000197	0.00133	CcSEcCtD
Ethotoin—Insomnia—Epirubicin—prostate cancer	0.000197	0.00133	CcSEcCtD
Ethotoin—Dermatitis—Capecitabine—prostate cancer	0.000197	0.00133	CcSEcCtD
Ethotoin—Headache—Capecitabine—prostate cancer	0.000196	0.00132	CcSEcCtD
Ethotoin—Nausea—Docetaxel—prostate cancer	0.000192	0.00129	CcSEcCtD
Ethotoin—Diarrhoea—Prednisone—prostate cancer	0.000191	0.00129	CcSEcCtD
Ethotoin—Fatigue—Epirubicin—prostate cancer	0.000188	0.00127	CcSEcCtD
Ethotoin—Nausea—Capecitabine—prostate cancer	0.000186	0.00125	CcSEcCtD
Ethotoin—Dizziness—Prednisone—prostate cancer	0.000184	0.00124	CcSEcCtD
Ethotoin—Insomnia—Doxorubicin—prostate cancer	0.000182	0.00123	CcSEcCtD
Ethotoin—Vomiting—Prednisone—prostate cancer	0.000177	0.00119	CcSEcCtD
Ethotoin—Rash—Prednisone—prostate cancer	0.000176	0.00118	CcSEcCtD
Ethotoin—Dermatitis—Prednisone—prostate cancer	0.000176	0.00118	CcSEcCtD
Ethotoin—Headache—Prednisone—prostate cancer	0.000175	0.00118	CcSEcCtD
Ethotoin—Fatigue—Doxorubicin—prostate cancer	0.000174	0.00117	CcSEcCtD
Ethotoin—Body temperature increased—Epirubicin—prostate cancer	0.000172	0.00116	CcSEcCtD
Ethotoin—Nausea—Prednisone—prostate cancer	0.000166	0.00112	CcSEcCtD
Ethotoin—Body temperature increased—Doxorubicin—prostate cancer	0.000159	0.00108	CcSEcCtD
Ethotoin—Asthenia—Epirubicin—prostate cancer	0.000156	0.00105	CcSEcCtD
Ethotoin—Phenobarbital—CYP3A4—prostate cancer	0.00015	0.0241	CrCbGaD
Ethotoin—Diarrhoea—Epirubicin—prostate cancer	0.000149	0.00101	CcSEcCtD
Ethotoin—Asthenia—Doxorubicin—prostate cancer	0.000145	0.000976	CcSEcCtD
Ethotoin—Dizziness—Epirubicin—prostate cancer	0.000144	0.000972	CcSEcCtD
Ethotoin—Vomiting—Epirubicin—prostate cancer	0.000139	0.000934	CcSEcCtD
Ethotoin—Diarrhoea—Doxorubicin—prostate cancer	0.000138	0.00093	CcSEcCtD
Ethotoin—Rash—Epirubicin—prostate cancer	0.000137	0.000927	CcSEcCtD
Ethotoin—Dermatitis—Epirubicin—prostate cancer	0.000137	0.000926	CcSEcCtD
Ethotoin—Headache—Epirubicin—prostate cancer	0.000137	0.000921	CcSEcCtD
Ethotoin—Dizziness—Doxorubicin—prostate cancer	0.000133	0.000899	CcSEcCtD
Ethotoin—Nausea—Epirubicin—prostate cancer	0.00013	0.000873	CcSEcCtD
Ethotoin—Vomiting—Doxorubicin—prostate cancer	0.000128	0.000865	CcSEcCtD
Ethotoin—Rash—Doxorubicin—prostate cancer	0.000127	0.000857	CcSEcCtD
Ethotoin—Dermatitis—Doxorubicin—prostate cancer	0.000127	0.000857	CcSEcCtD
Ethotoin—Headache—Doxorubicin—prostate cancer	0.000126	0.000852	CcSEcCtD
Ethotoin—Nausea—Doxorubicin—prostate cancer	0.00012	0.000808	CcSEcCtD
Ethotoin—SCN5A—Developmental Biology—KDR—prostate cancer	3.94e-05	0.000235	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—EGFR—prostate cancer	3.89e-05	0.000232	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—EGFR—prostate cancer	3.89e-05	0.000232	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—MMP9—prostate cancer	3.88e-05	0.000232	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—EGFR—prostate cancer	3.87e-05	0.000231	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—GSTM1—prostate cancer	3.85e-05	0.00023	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—KRAS—prostate cancer	3.81e-05	0.000228	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—KRAS—prostate cancer	3.81e-05	0.000228	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—GSTM1—prostate cancer	3.79e-05	0.000227	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—CTNNB1—prostate cancer	3.78e-05	0.000226	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—IL6—prostate cancer	3.77e-05	0.000225	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—MMP9—prostate cancer	3.71e-05	0.000221	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—EP300—prostate cancer	3.68e-05	0.00022	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—KRAS—prostate cancer	3.68e-05	0.00022	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—KRAS—prostate cancer	3.68e-05	0.00022	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—KRAS—prostate cancer	3.66e-05	0.000219	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—IL6—prostate cancer	3.65e-05	0.000218	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—CYP1A1—prostate cancer	3.65e-05	0.000218	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—CTNNB1—prostate cancer	3.63e-05	0.000217	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—CTNNB1—prostate cancer	3.63e-05	0.000217	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—HAO1—prostate cancer	3.6e-05	0.000215	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—CYP1A1—prostate cancer	3.6e-05	0.000215	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—SRC—prostate cancer	3.58e-05	0.000213	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—MMP9—prostate cancer	3.56e-05	0.000213	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—MMP9—prostate cancer	3.56e-05	0.000213	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—EP300—prostate cancer	3.52e-05	0.00021	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—CTNNB1—prostate cancer	3.51e-05	0.000209	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—CTNNB1—prostate cancer	3.51e-05	0.000209	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—VEGFA—prostate cancer	3.48e-05	0.000208	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—GSK3B—prostate cancer	3.48e-05	0.000208	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—STAT3—prostate cancer	3.45e-05	0.000206	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—MMP9—prostate cancer	3.44e-05	0.000205	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—MMP9—prostate cancer	3.44e-05	0.000205	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—INS—prostate cancer	3.43e-05	0.000205	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—SRC—prostate cancer	3.42e-05	0.000204	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—MMP9—prostate cancer	3.39e-05	0.000202	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—EP300—prostate cancer	3.38e-05	0.000202	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—EP300—prostate cancer	3.38e-05	0.000202	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—IL6—prostate cancer	3.37e-05	0.000202	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—AKT1—prostate cancer	3.37e-05	0.000201	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—CREBBP—prostate cancer	3.36e-05	0.000201	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	3.36e-05	0.0002	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—VEGFA—prostate cancer	3.33e-05	0.000199	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—STAT3—prostate cancer	3.3e-05	0.000197	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—SRC—prostate cancer	3.29e-05	0.000196	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—SRC—prostate cancer	3.29e-05	0.000196	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—EP300—prostate cancer	3.26e-05	0.000195	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—EP300—prostate cancer	3.26e-05	0.000195	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—IL6—prostate cancer	3.26e-05	0.000194	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—IL6—prostate cancer	3.23e-05	0.000193	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	3.22e-05	0.000192	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MMP2—prostate cancer	3.21e-05	0.000192	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MAP2K1—prostate cancer	3.21e-05	0.000192	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—VEGFA—prostate cancer	3.2e-05	0.000191	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—VEGFA—prostate cancer	3.2e-05	0.000191	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—TGFB1—prostate cancer	3.2e-05	0.000191	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—STAT3—prostate cancer	3.17e-05	0.000189	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—STAT3—prostate cancer	3.17e-05	0.000189	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—SRC—prostate cancer	3.17e-05	0.000189	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—SRC—prostate cancer	3.17e-05	0.000189	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—EGFR—prostate cancer	3.13e-05	0.000187	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—SRC—prostate cancer	3.12e-05	0.000186	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—IL6—prostate cancer	3.1e-05	0.000185	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—IL6—prostate cancer	3.1e-05	0.000185	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	3.1e-05	0.000185	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—VEGFA—prostate cancer	3.09e-05	0.000184	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—VEGFA—prostate cancer	3.09e-05	0.000184	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—TGFB1—prostate cancer	3.06e-05	0.000183	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—STAT3—prostate cancer	3.06e-05	0.000182	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—STAT3—prostate cancer	3.06e-05	0.000182	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—FGF2—prostate cancer	3.05e-05	0.000182	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—VEGFA—prostate cancer	3.04e-05	0.000182	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—AKT1—prostate cancer	3e-05	0.000179	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—EGFR—prostate cancer	3e-05	0.000179	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	2.99e-05	0.000179	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—IL6—prostate cancer	2.99e-05	0.000179	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—IL6—prostate cancer	2.99e-05	0.000179	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—IL6—prostate cancer	2.98e-05	0.000178	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—KRAS—prostate cancer	2.96e-05	0.000177	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—TGFB1—prostate cancer	2.94e-05	0.000175	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—TGFB1—prostate cancer	2.94e-05	0.000175	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GRHL1—prostate cancer	2.93e-05	0.000175	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CSAD—prostate cancer	2.93e-05	0.000175	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PSAT1—prostate cancer	2.93e-05	0.000175	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ADI1—prostate cancer	2.93e-05	0.000175	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TST—prostate cancer	2.93e-05	0.000175	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CBR1—prostate cancer	2.93e-05	0.000175	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—JAK2—prostate cancer	2.93e-05	0.000175	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—EGFR—prostate cancer	2.88e-05	0.000172	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—EGFR—prostate cancer	2.88e-05	0.000172	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	2.87e-05	0.000171	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—TGFB1—prostate cancer	2.83e-05	0.000169	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—TGFB1—prostate cancer	2.83e-05	0.000169	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—KRAS—prostate cancer	2.83e-05	0.000169	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—ERBB2—prostate cancer	2.82e-05	0.000168	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	2.81e-05	0.000168	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—EGFR—prostate cancer	2.78e-05	0.000166	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—EGFR—prostate cancer	2.78e-05	0.000166	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—AKT1—prostate cancer	2.75e-05	0.000164	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—EGFR—prostate cancer	2.74e-05	0.000163	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—UGT2B17—prostate cancer	2.73e-05	0.000163	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—UGT2B15—prostate cancer	2.73e-05	0.000163	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CKMT2—prostate cancer	2.73e-05	0.000163	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GRHPR—prostate cancer	2.73e-05	0.000163	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—KRAS—prostate cancer	2.72e-05	0.000162	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—KRAS—prostate cancer	2.72e-05	0.000162	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	2.67e-05	0.000159	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—KRAS—prostate cancer	2.62e-05	0.000157	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—KRAS—prostate cancer	2.62e-05	0.000157	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—MED12—prostate cancer	2.62e-05	0.000157	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—KRAS—prostate cancer	2.58e-05	0.000154	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTM3—prostate cancer	2.56e-05	0.000153	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SULT2B1—prostate cancer	2.56e-05	0.000153	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PGAM2—prostate cancer	2.56e-05	0.000153	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—AOX1—prostate cancer	2.56e-05	0.000153	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NAGLU—prostate cancer	2.56e-05	0.000153	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—RFK—prostate cancer	2.56e-05	0.000153	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—MBTPS1—prostate cancer	2.56e-05	0.000153	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	2.51e-05	0.00015	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—CTNNB1—prostate cancer	2.46e-05	0.000147	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP3A43—prostate cancer	2.43e-05	0.000145	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—AMACR—prostate cancer	2.43e-05	0.000145	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SRD5A2—prostate cancer	2.43e-05	0.000145	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NAT1—prostate cancer	2.43e-05	0.000145	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—DEGS1—prostate cancer	2.43e-05	0.000145	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—MMP9—prostate cancer	2.42e-05	0.000144	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—IL6—prostate cancer	2.41e-05	0.000144	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	2.39e-05	0.000143	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—HSD17B1—prostate cancer	2.32e-05	0.000138	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	2.32e-05	0.000138	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—IL6—prostate cancer	2.3e-05	0.000138	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—EP300—prostate cancer	2.29e-05	0.000137	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	2.23e-05	0.000133	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—SRC—prostate cancer	2.23e-05	0.000133	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—AKT1—prostate cancer	2.22e-05	0.000133	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	2.22e-05	0.000132	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—IL6—prostate cancer	2.21e-05	0.000132	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—IL6—prostate cancer	2.21e-05	0.000132	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	2.2e-05	0.000131	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—VEGFA—prostate cancer	2.17e-05	0.00013	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—STAT3—prostate cancer	2.15e-05	0.000128	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—IL6—prostate cancer	2.13e-05	0.000127	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—IL6—prostate cancer	2.13e-05	0.000127	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—AKT1—prostate cancer	2.13e-05	0.000127	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—IL6—prostate cancer	2.1e-05	0.000126	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	2.09e-05	0.000125	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—HPGD—prostate cancer	2.07e-05	0.000123	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—B4GALT4—prostate cancer	2.07e-05	0.000123	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—AKT1—prostate cancer	2.04e-05	0.000122	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—AKT1—prostate cancer	2.04e-05	0.000122	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—TGFB1—prostate cancer	1.99e-05	0.000119	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—AKT1—prostate cancer	1.97e-05	0.000118	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—AKT1—prostate cancer	1.97e-05	0.000118	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—EGFR—prostate cancer	1.95e-05	0.000117	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TNFRSF21—prostate cancer	1.94e-05	0.000116	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP7B1—prostate cancer	1.89e-05	0.000113	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—MTAP—prostate cancer	1.89e-05	0.000113	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.85e-05	0.00011	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—KRAS—prostate cancer	1.84e-05	0.00011	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SRD5A1—prostate cancer	1.84e-05	0.00011	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SULT1E1—prostate cancer	1.84e-05	0.00011	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.79e-05	0.000107	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.76e-05	0.000105	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ACSL4—prostate cancer	1.76e-05	0.000105	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—HSD17B3—prostate cancer	1.76e-05	0.000105	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.74e-05	0.000104	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ARG2—prostate cancer	1.68e-05	0.000101	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PHGDH—prostate cancer	1.68e-05	0.000101	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—UMPS—prostate cancer	1.68e-05	0.000101	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.68e-05	0.0001	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—LDHB—prostate cancer	1.65e-05	9.87e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP3A5—prostate cancer	1.62e-05	9.69e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTA3—prostate cancer	1.57e-05	9.35e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TCN2—prostate cancer	1.57e-05	9.35e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—UCP3—prostate cancer	1.57e-05	9.35e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PDHA1—prostate cancer	1.57e-05	9.35e-05	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—IL6—prostate cancer	1.5e-05	8.96e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—HSD3B1—prostate cancer	1.49e-05	8.92e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SLC22A3—prostate cancer	1.49e-05	8.92e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.45e-05	8.66e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTA4—prostate cancer	1.43e-05	8.56e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TBXAS1—prostate cancer	1.43e-05	8.56e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.4e-05	8.36e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTA2—prostate cancer	1.4e-05	8.34e-05	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—AKT1—prostate cancer	1.38e-05	8.27e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ABCG5—prostate cancer	1.38e-05	8.24e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SULT1A1—prostate cancer	1.38e-05	8.24e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTA1—prostate cancer	1.35e-05	8.04e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTO1—prostate cancer	1.33e-05	7.95e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NAT2—prostate cancer	1.33e-05	7.95e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—HSD3B2—prostate cancer	1.33e-05	7.95e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.28e-05	7.65e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PLCB2—prostate cancer	1.28e-05	7.63e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—LRP2—prostate cancer	1.28e-05	7.63e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP2C18—prostate cancer	1.28e-05	7.63e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—P4HB—prostate cancer	1.25e-05	7.48e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SLC22A1—prostate cancer	1.22e-05	7.27e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.2e-05	7.19e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SULT2A1—prostate cancer	1.19e-05	7.09e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—MED12—prostate cancer	1.17e-05	6.97e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GNG5—prostate cancer	1.16e-05	6.92e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NCOA3—prostate cancer	1.12e-05	6.67e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.1e-05	6.55e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—HPGDS—prostate cancer	1.06e-05	6.36e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTT1—prostate cancer	1.03e-05	6.17e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ACHE—prostate cancer	1.03e-05	6.17e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP2A6—prostate cancer	1.02e-05	6.1e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.02e-05	6.07e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—AKR1C3—prostate cancer	9.93e-06	5.93e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PRKACB—prostate cancer	9.88e-06	5.9e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP17A1—prostate cancer	9.78e-06	5.84e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	9.64e-06	5.76e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NCOA2—prostate cancer	9.32e-06	5.56e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—SLC5A5—prostate cancer	8.89e-06	5.31e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP2E1—prostate cancer	8.68e-06	5.18e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NQO1—prostate cancer	8.58e-06	5.13e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TH—prostate cancer	8.46e-06	5.05e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	8.4e-06	5.02e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP3A4—prostate cancer	8.37e-06	5e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	8.33e-06	4.97e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP1B1—prostate cancer	8.23e-06	4.91e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GGT1—prostate cancer	7.97e-06	4.76e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NCOA1—prostate cancer	7.85e-06	4.69e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP19A1—prostate cancer	7.74e-06	4.62e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—RXRA—prostate cancer	7.47e-06	4.46e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	7.26e-06	4.34e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—COMT—prostate cancer	7.19e-06	4.3e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTP1—prostate cancer	7.16e-06	4.27e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ITPR1—prostate cancer	7.04e-06	4.21e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.93e-06	4.14e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TYMS—prostate cancer	6.66e-06	3.97e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTM1—prostate cancer	6.58e-06	3.93e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—LPL—prostate cancer	6.46e-06	3.86e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP1A1—prostate cancer	6.24e-06	3.72e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ERCC2—prostate cancer	6.19e-06	3.69e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—MTHFR—prostate cancer	5.81e-06	3.47e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PPARA—prostate cancer	5.7e-06	3.41e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CAV1—prostate cancer	5.36e-06	3.2e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.12e-06	3.06e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PIK3CG—prostate cancer	4.88e-06	2.92e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—INS—prostate cancer	4.62e-06	2.76e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CREBBP—prostate cancer	4.53e-06	2.7e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PIK3CD—prostate cancer	4.29e-06	2.56e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NOS3—prostate cancer	4.05e-06	2.42e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PIK3CB—prostate cancer	3.74e-06	2.24e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PTGS2—prostate cancer	3.71e-06	2.21e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PTEN—prostate cancer	3.23e-06	1.93e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—EP300—prostate cancer	3.08e-06	1.84e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PIK3CA—prostate cancer	2.28e-06	1.36e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—AKT1—prostate cancer	1.86e-06	1.11e-05	CbGpPWpGaD
